Scinai Immunotherapeutics Ltd (SCNI) — Cash Flow Quality Index
Scinai Immunotherapeutics Ltd (SCNI) has a Cash Flow Quality Index of -0.41x as of March 2026. Operating cash flow of $-1.45 Million is below net income of $3.57 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Scinai Immunotherapeutics Ltd to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Scinai Immunotherapeutics Ltd Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Scinai Immunotherapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see SCNI cash generation efficiency.
Annual Cash Flow Quality Index for Scinai Immunotherapeutics Ltd (2024–2024)
Year-by-year earnings quality comparison for Scinai Immunotherapeutics Ltd.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.32x | $-6.33 Million | $4.80 Million | — |